Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_assertion type Assertion NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_head.
- NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_assertion description "[Using reverse transcription-polymerase chain reaction, Semenogelin 1 gene was frequently expressed in chronic myeloid leukemia (5 of 8, 62.5%) and chronic lymphocytic leukemia (5 of 12, 41.7%) but rarely in multiple myeloma (2 of 30, 6.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_provenance.
- NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_assertion evidence source_evidence_literature NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_provenance.
- NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_assertion SIO_000772 14595213 NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_provenance.
- NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_assertion wasDerivedFrom befree-2016 NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_provenance.
- NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_assertion wasGeneratedBy ECO_0000203 NP418975.RACVyOqWHYPNlUQ_1Pr8FeY7CT8TGHpCPd71grlNzm1Cs130_provenance.